Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001104659-24-022561 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-09 | INSP | Weatherby Carlton | Chief Strategy Off | A - Grant | $0.00 | +2,694 | 2,694 | New | $0 |
| D | 2024-02-13 | 2024-02-09 | INSP | Weatherby Carlton | Chief Strategy Off | A - Grant | $0.00 | +4,376 | 4,376 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | A | A | 2,694 | $0.00 | 2,694 | D | — | — | (F1) Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2024-02-09 | A | A | 4,376 | $0.00 | 4,376 | D | $194.87 · — to 2034-02-09 | 4,376 Common Stock | (F2) The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |